| Ident. | Authors (with country if any) | Title |
|---|
| 001518 (2012) |
QIAN XU [Canada, République populaire de Chine] ; HONGLING GUO [Canada] ; XIAOJIE ZHANG [Canada] ; BEISHA TANG [République populaire de Chine] ; FANG CAI [Canada] ; WEIHUI ZHOU [République populaire de Chine] ; WEIHONG SONG [Canada, République populaire de Chine] | Hypoxia regulation of ATP13A2 (PARK9) gene transcription |
| 001932 (2011) |
RUITAO WANG [Canada, République populaire de Chine] ; MINGMING ZHANG [Canada] ; WEIHUI ZHOU [Canada] ; Philip T. T. Ly [Canada] ; FANG CAI [Canada] ; WEIHONG SONG [Canada] | NF-κB signaling inhibits ubiquitin carboxyl-terminal hydrolase L1 gene expression |
| 002644 (2007) |
Jennifer E. Tobin [États-Unis] ; JING CUI [États-Unis] ; Jemma B. Wilk [États-Unis] ; Jeanne C. Latourelle [États-Unis] ; Jason M. Laramie [États-Unis] ; Ann C. Mckee [États-Unis] ; Mark Guttman [Canada] ; Samer Karamohamed [États-Unis] ; Anita L. Destefano [États-Unis] ; Richard H. Myers [États-Unis] | Sepiapterin reductase expression is increased in Parkinson's disease brain tissue |
| 002670 (2007) |
HAORAN WANG [Canada, République populaire de Chine] ; Mary X. Gao [Canada, Japon] ; LINDA LI [République populaire de Chine] ; BIN WANG [République populaire de Chine] ; Naohiro Hori [Japon] ; Kenzo Sato [Japon] | Isolation, expression, and characterization of the human ZCRB1 gene mapped to 12q12 |
| 002F12 (2003) |
Sophie Vigouroux [France] ; Yoshiaki Furukawa [Canada] ; Luc Farout [France] ; Stephen J. Kish [Canada] ; Marièle Briand [France] ; Yves Briand [France] | Peptidase activities of the 20/26S proteasome and a novel protease in human brain |
| 002F34 (2003) |
Kelly L. Jordan-Sciutto [États-Unis] ; Robert Dorsey [États-Unis] ; Elisabeth M. Chalovich [États-Unis] ; Robert R. Hammond [Canada] ; Cristian L. Achim [États-Unis] | Expression patterns of retinoblastoma protein in Parkinson disease |
| 003075 (2002) |
Kristen J. Armstrong [Canada] ; Lennard P. Niles [Canada] | Induction of GDNF mRNA expression by melatonin in rat C6 glioma cells |
| 003307 (2001) |
K. Tieu [Canada] ; P. C. Ashe [Canada] ; D. M. Zuo [Canada] ; P. H. Yu [Canada] | Inhibition of 6-hydroxydopamine-induced p53 expression and survival of neuroblastoma cells following interaction with astrocytes |
| 003329 (2001) |
Poornima K. Tekumalla [États-Unis] ; Frédéric Calon [Canada] ; Zia Rahman [États-Unis] ; Sam Birdi [Canada] ; Ali H. Rajput [Canada] ; Oleh Hornykiewicz [Canada, Autriche] ; Therese Di Paolo [Canada] ; Paul J. Bedard [Canada] ; Eric J. Nestler [États-Unis] | Elevated levels of ΔFosB and RGS9 in striatum in Parkinson's disease |
| 003512 (2000) |
Frédéric Calon [Canada] ; Abdallah Hadj Tahar [Canada] ; Pierre J. Blanchet [Canada] ; Marc Morissette [Canada] ; Richard Grondin [Canada] ; Martin Goulet [Canada] ; Jean-Pierre Doucet [Canada] ; George S. Robertson [Canada] ; Eric Nestler [États-Unis] ; Thérèse Di Paolo [Canada] ; Paul J. Bédard [Canada] | Dopamine-receptor stimulation: biobehavioral and biochemical consequences |
| 003562 (2000) |
M. Goulet [Canada] ; R. Grondin [Canada] ; M. Morissette [Canada] ; S. Maltais [Canada] ; P. Falardeau [Canada] ; P. J. Bedard [Canada] ; T. Di Paolo [Canada] | Regulation by chronic treatment with cabergoline of dopamine D1 and D2 receptor levels and their expression in the striatum of Parkinsonian-Monkeys |
| 003666 (1999) |
G. Flores [Mexique] ; J. J Liang ; A. Sierra [Mexique] ; D. Mart Nez-Fong [Mexique] ; R. Quirion ; J. Aceves [Mexique] ; L. K Srivastava | Expression of dopamine receptors in the subthalamic nucleus of the rat: characterization using reverse transcriptase–polymerase chain reaction and autoradiography |
| 003824 (1999) |
T. Inoue [Canada, Japon] ; J. Tsui [Canada] ; N. Wong [Canada] ; SHIN YI WONG [Canada] ; F. Suzuki [Japon] ; YIN NAM KWOK [Canada] | Expression of glial cell line-derived neurotrophic factor and its mRNA in the nigrostriatal pathway following MPTP treatment |
| 003878 (1998) |
Douglas G. Walker [Canada] ; Thomas G. Beach [Canada, États-Unis] ; Ren Xu [États-Unis] ; Jack Lile [États-Unis] ; Klaus D. Beck [États-Unis] ; Edith G. Mcgeer [Canada] ; Patrick L. Mcgeer [Canada] | Expression of the proto-oncogene Ret, a component of the GDNF receptor complex, persists in human substantia nigra neurons in Parkinson's disease |
| 003A27 (1998) |
H. M. Schipper [Canada] ; A. Liberman [Canada] ; E. G. Stopa [États-Unis] | Neural heme oxygenase-1 expression in idiopathic Parkinson's disease |
| 003B34 (1997) |
M. Goulet [Canada] ; M. Morissette [Canada] ; F. Calon [Canada] ; P. J Blanchet [Canada] ; P. Falardeau [Canada] ; P. J Bédard [Canada] ; T. Di Paolo [Canada] | Continuous or pulsatile chronic D2 dopamine receptor agonist (U91356A) treatment of drug-naive 4-phenyl-1,2,3,6-tetrahydropyridine monkeys differentially regulates brain D1 and D2 receptor expression: in situ hybridization histochemical analysis |
| 003D21 (1996) |
Jean-Jacques Soghomonian [Canada] ; Sophie Pedneault [Canada] ; Pierre J. Blanchet [Canada] ; Martin Goulet [Canada] ; Thérèse Di Paolo [Canada] ; Paul J. Bédard [Canada] | l-DOPA regulates glutamate decarboxylases mRNA levels in MPTP-treated monkeys |
| 003E90 (1996) |
W. G. Tatton [Canada] ; R. M. E. Chalmers-Redman [Canada] | Modulation of gene expression rather than monoamine oxidase inhibition : (-)-Deprenyl-related compounds in controlling neurodegeneration |
| 004294 (1994) |
M.-C. Asselin [Canada] ; J.-J. Soghomonian ; P.-Y. Côte ; A. Parent | Striatal changes in preproenkephalin mRNA levels in parkinsonian monkeys |
| 004301 (1994) |
O. Yasuhara [Canada] ; T. Kawamata ; Y. Aimi ; E. G. Mcgeer ; P. L. Mcgeer | Expression of chromogranin A in lesions in the central nervous system from patients with neurological diseases |
| 004654 (1992) |
M. L. Paul [Canada] ; A. M. Graybiel ; J.-C. David ; H. A. Robertson [Canada] | D1-like and D2-like dopamine receptors synergistically actitave rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease |
